Phibro Animal Health (PAHC) Non-Current Assets (2013 - 2026)
Phibro Animal Health (PAHC) posted Non-Current Assets of $565.7 million for Q2 2026, up 2.66% on a QoQ basis from $551.0 million in Q1 2026, and up 2.81% year-over-year from $550.3 million in Q2 2025.
Analysis
Phibro Animal Health (PAHC) Non-Current Assets (2013 - 2026) Analysis & Trends
Phibro Animal Health has reported Non-Current Assets for 14 years, with the latest figure at $565.7 million in Q2 2026.
- On a quarterly basis, Non-Current Assets rose 2.81% year-over-year to $565.7 million in Q2 2026; TTM through Jun 2026 was $2.2 billion, a 9.05% increase from a year earlier, with the FY2026 full-year figure at $565.7 million, up 2.81% from the prior year.
- Non-Current Assets was $565.7 million for Q2 2026 at Phibro Animal Health, up from $551.0 million in the prior quarter.
- The five-year high for Non-Current Assets was $565.7 million in Q2 2026, with the low at $365.5 million in Q2 2022.
- Average Non-Current Assets over 5 years is $445.8 million, with a median of $385.9 million recorded in 2023.
- The sharpest annual moves came in 2024 and 2025: Non-Current Assets declined 1.16% in 2024, then surged 44.36% in 2025.
- Over 5 years, Non-Current Assets stood at $380.1 million in 2022, then gained by 1.57% to $386.1 million in 2023, then jumped by 39.69% to $539.4 million in 2024, then gained by 0.74% to $543.4 million in 2025, then increased by 4.12% to $565.7 million in 2026.
- The last three Non-Current Assets figures came in at $565.7 million (Q2 2026), $551.0 million (Q1 2026), and $543.4 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | 1.93 Bn |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | 8.72 Bn |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | 9.76 Bn |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | 565.74 Mn |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | 25.55 Mn |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | 42.16 Mn |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | 268,652.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 565.74 Mn |
| Mar 31, 2026 | 551.05 Mn |
| Dec 31, 2025 | 543.37 Mn |
| Sep 30, 2025 | 549.73 Mn |
| Jun 30, 2025 | 550.29 Mn |
| Mar 31, 2025 | 541.24 Mn |
| Dec 31, 2024 | 539.36 Mn |
| Sep 30, 2024 | 395.52 Mn |
| Jun 30, 2024 | 381.19 Mn |
| Mar 31, 2024 | 381.86 Mn |
| Dec 31, 2023 | 386.12 Mn |
| Sep 30, 2023 | 380.10 Mn |
| Jun 30, 2023 | 385.67 Mn |
| Mar 31, 2023 | 379.95 Mn |
| Dec 31, 2022 | 380.14 Mn |
| Sep 30, 2022 | 378.30 Mn |
| Jun 30, 2022 | 365.47 Mn |
| Mar 31, 2022 | 369.70 Mn |
| Dec 31, 2021 | 340.35 Mn |
| Sep 30, 2021 | 337.41 Mn |